Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Maude Bouscambert‐Duchamp et al.|The Lancet Infectious Diseases|2021Cited by 344
Tuberculosis in HIV-infected patients: a comprehensive reviewLaurent Aaron, Olivier Lortholary, N. Mémain et al.|Clinical Microbiology and Infection|2004Cited by 332